Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01922895
What this trial is testing

Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis

Who this might be right for
Acute Alcoholic Hepatitis
University of Texas Southwestern Medical Center 45
Large-scale testing (Phase 3)Study completedNCT01909557
What this trial is testing

Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.

Who this might be right for
Quality of LifeDaily ActivityFatigue
University of Catania 62
Post-approval studies (Phase 4)Study completedNCT01195181
What this trial is testing

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Who this might be right for
Hepatitis C VirusChronic Liver DiseaseViral Hepatitis+2 more
Azienda Ospedaliera di Padova 506
Post-approval studies (Phase 4)UnknownNCT04069858
What this trial is testing

Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Korea University 40
Not applicableNot Yet RecruitingNCT07017426
What this trial is testing

Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Who this might be right for
Decompensated Hepatitis B Cirrhosis
Zhiyun Yang 432
Post-approval studies (Phase 4)Study completedNCT00266318
What this trial is testing

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Who this might be right for
Hepatitis C
Beth Israel Medical Center 40
Post-approval studies (Phase 4)Study completedNCT01684787
What this trial is testing

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Who this might be right for
Chronic Hepatitis C
Miguel Santin 80
Not applicableNot Yet RecruitingNCT07053449
What this trial is testing

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Who this might be right for
Hepatitis B Virus (HBV)
Nottingham University Hospitals NHS Trust 30
Large-scale testing (Phase 3)Study completedNCT00275938
What this trial is testing

Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
National Taiwan University Hospital 120
Post-approval studies (Phase 4)UnknownNCT02644538
What this trial is testing

Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides

Who this might be right for
Hepatitis B
The Second Affiliated Hospital of Chongqing Medical University 196
Not applicableStudy completedNCT00591968
What this trial is testing

Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community

Who this might be right for
AscitesBlunt Abdominal TraumaCholelithiasis+11 more
Edward Via Virginia College of Osteopathic Medicine 106
Not applicableUnknownNCT05751889
What this trial is testing

Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM

Who this might be right for
Viral Hepatitis C
National Taiwan University Hospital 1,320
Not applicableStudy completedNCT01416610
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Ended earlyNCT03932513
What this trial is testing

Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients

Who this might be right for
HBVHepatitis BHepatitis B, Chronic
F-star Therapeutics, Inc. 8
Not applicableStudy completedNCT00596960
What this trial is testing

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

Who this might be right for
Alcohol DependenceChronic Hepatitis C
US Department of Veterans Affairs 139
Not applicableEnrolling By InvitationNCT06463223
What this trial is testing

HIBOC = Hepatic Imaging Biomarkers in Obese Children

Who this might be right for
ElastographyShear Wave ElastographyShear Wave Dispersion+8 more
Sahlgrenska University Hospital 300
Not applicableStudy completedNCT01200225
What this trial is testing

An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,155
Not applicableStudy completedNCT01863589
What this trial is testing

Drug Use Investigation for HEPSERA (Adefovir) Tablet

Who this might be right for
Hepatitis B
GlaxoSmithKline 436
Not applicableStudy completedNCT06289868
What this trial is testing

Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)

Who this might be right for
HAV
Beckman Coulter, Inc. 1,409
Not applicableStudy completedNCT00916474
What this trial is testing

Virology Follow up Study in Subjects Previously Treated With Telaprevir

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 408
Next Page